Last reviewed · How we verify
NCT06095622: DP-Trails
Chickpea Pulao Using Fenugreek Seeds and Indian Rennet for Improving Blood Glycaemic Levels
NA trial testing Fenugreek Seeds and Indian Rennet in Glucose Metabolism Disorders (Including Diabetes Mellitus) in 12 participants. Completed in 30 August 2023.
30 July 2023
Quick facts
| Lead sponsor | University of Management and Technology Lahore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 12 |
| Start date | 15 March 2023 |
| Primary completion | 30 July 2023 |
| Estimated completion | 30 August 2023 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Fenugreek Seeds and Indian Rennet
Conditions studied
- Glucose Metabolism Disorders (Including Diabetes Mellitus) — all drugs for Glucose Metabolism Disorders (Including Diabetes Mellitus) →
Sponsor
University of Management and Technology Lahore
Who can join
Adults 35 to 65, any sex, with Glucose Metabolism Disorders (Including Diabetes Mellitus). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study was to perform a clinical trial to compare the impact of herbal chickpea pulao (cooked Indian-Pakistani rice dish) on improving postprandial blood glucose levels in type-2 diabetic people. The main questions it aims to answer are: * Whether Indian rennet and fenugreek seed extract can modulate blood sugar levels or not? * At what concentration the flavor, taste, and blood sugar impact were acceptable? Participants were provided with control and intervention herbal chickpea pulao for a period of 21 days and asked to provide feedback on taste, flavor, and over-acceptability, and their postprandial blood glucose levels were checked.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06095622
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glucose Metabolism Disorders (Including Diabetes Mellitus)
Currently open trials in the same condition.
- NCT06575426 — A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes M · Phase 1, PHASE2 · recruiting
- NCT06529965 — Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM · NA · recruiting
- NCT05764200 — Acute Microbial Switch · NA · recruiting
- NCT06334172 — The Role of Oxytocin in Regulating Blood Glucose · NA · recruiting
- NCT07172009 — The Effect of Chlorhexidine Mouthwash on Postprandial Glucose Response in Healthy Individuals · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06095622 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Management and Technology Lahore
- Last refreshed: 23 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06095622.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing